← Leaderboards
Dalia Elgamal
Ohio State University
$886,253
Attributed
$886,253
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $249K · FY2016–20$250K$187.5K$125K$62.5K$0
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$886,253 · 2
By mechanism
R00$679,465 · 1
K99$206,788 · 1
Top collaborators
No co-investigators on record.
Most similar at Ohio State University
Same institution · by research overlap
- Jennifer A. Woyach$6,733,332
- Michael A Caligiuri$65,062,344
- Rosa Lapalombella$5,349,017
- Deepa Sampath$2,215,864
- David P Carbone$20,647,321
Others in their field
Top investigators on “Diagnostic Tests”
- Leonard Freedman · Leidos Biomedical Research, Inc.$245,503,168
- Ralph Parchment · Leidos Biomedical Research, Inc.$159,723,588
- David R. Weir · University Of Michigan At Ann Arbor$143,453,201
- Michael W Weiner · Northern California Institute Res &Educ$132,926,566
- David Heimbrook · Leidos Biomedical Research, Inc.$131,050,466
- Sharon L Hillier · Magee-Women'S Hospital Of Upmc$119,839,039
Research focus
Diagnostic TestsDisease ModelAdoptive TransferDefectDiagnostic BiomarkerBcl2 GeneBinding ProteinsAttenuatedAutomobile DrivingB-LymphocytesBromodomainB-Cell LymphomasCdkn2a GeneCell GrowthCell ProliferationChromatinChromatin ImmunoprecipitationBiological MarkersChronic Lymphocytic LeukemiaBiologyComplexComplicationCurative TreatmentsDisease Progression
Grant awards (5)
Targeting BRD4 in Chronic Lymphocytic Leukemia (CLL) Disease Progression to Richter's Transformation (RT)$249,000
R00 · FY2020 · CA · contact PI
Targeting BRD4 in Chronic Lymphocytic Leukemia (CLL) Disease Progression to Richter's Transformation (RT)$181,465
R00 · FY2019 · CA · contact PI
Targeting BRD4 in Chronic Lymphocytic Leukemia (CLL) Disease Progression to Richter's Transformation (RT)$249,000
R00 · FY2018 · CA · contact PI
Targeting BRD4 in Chronic Lymphocytic Leukemia (CLL) Disease Progression to Richter's Transformation (RT)$103,394
K99 · FY2017 · CA · contact PI
Targeting BRD4 in Chronic Lymphocytic Leukemia (CLL) Disease Progression to Richter's Transformation (RT)$103,394
K99 · FY2016 · CA · contact PI